{
    "clinical_study": {
        "@rank": "14959", 
        "arm_group": [
            {
                "arm_group_label": "Clonidine", 
                "arm_group_type": "Experimental", 
                "description": "Clonidine 150\u03bcg  added to bupivacaine in a local infiltration before wound incision"
            }, 
            {
                "arm_group_label": "Bupivacaine", 
                "arm_group_type": "Active Comparator", 
                "description": "Bupivacaine 0.25 % alone in the wound infiltration"
            }
        ], 
        "brief_summary": {
            "textblock": "The objective of this prospective randomized double-blind study is to evaluate the added\n      analgesic value of clonidine to the conventional local bupivacaine wound infiltration in\n      posterior spine surgery."
        }, 
        "brief_title": "Added Value of Local Clonidine for Spine Postoperative Pain Control, in Addition to Bupivacaine", 
        "completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Post-operative Pain", 
        "condition_browse": {
            "mesh_term": "Pain, Postoperative"
        }, 
        "detailed_description": {
            "textblock": "Patients candidates to posterior spine surgery (Micro-discectomy, Lumbar laminectomy with or\n      without fusion, cervical laminectomy) are asked to participate to this prospective study.\n      After verification of inclusion and exclusion criteria, patients consenting to enter the\n      study are randomly assigned to one of the following subgroups: 1-Pre-incisional wound\n      infiltration with 20 mL of bupivacaine 0.25%.          2- Pre-incisional wound infiltration\n      with 150 \u03bcg of clonidine with 20 mL of bupivacaine 0.25%. Demographic parameters,\n      co-morbidities and other pre and per operative medical data are noted. In the post-operative\n      period, patients received a standardized post-operative analgesic protocol (NSAI and\n      paracetamol). Patients are asked to fill their pain diary using Visual Analog Scale (VAS)\n      from day 0 till day 8 after surgery. Morphine rescue consumption is noted. Finally, the\n      percentage of global subjective patient satisfaction regarding the post-operative wound pain\n      is noted from 0 to 100."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  First (not recurrent) posterior spinal surgery at the operated site\n\n          -  American Society of Anesthesiologists class I or II (operative risk)\n\n        Exclusion Criteria:\n\n          -  Allergy to local anesthetics or to clonidine\n\n          -  Pregnancy\n\n          -  Raynaud's syndrome\n\n          -  Thromboangiitis obliterans\n\n          -  History of substance abuse\n\n          -  Current treatment with corticosteroids"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "72 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "200", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 7, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01902108", 
            "org_study_id": "CLON-POBPC"
        }, 
        "intervention": [
            {
                "arm_group_label": "Bupivacaine", 
                "description": "Local infiltration before wound incision with 20 ml of Bupivacaine 0.25 % alone", 
                "intervention_name": "Bupivacaine", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Clonidine", 
                "description": "Clonidine 150\u03bcg locally infiltrated with 20 ml of bupivacaine 0.25 % before wound incision", 
                "intervention_name": "Clonidine", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Bupivacaine", 
                "Clonidine"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "clonidine", 
            "bupivacaine", 
            "post-operative pain", 
            "arthrodesis", 
            "discectomy", 
            "local infiltration"
        ], 
        "lastchanged_date": "July 17, 2013", 
        "location": {
            "contact": {
                "email": "joseph.maarrawi@usj.edu.lb", 
                "last_name": "Joseph Maarrawi, MD, PhD", 
                "phone": "009611615300", 
                "phone_ext": "9513"
            }, 
            "facility": {
                "address": {
                    "city": "Beirut", 
                    "country": "Lebanon", 
                    "zip": "16-6830"
                }, 
                "name": "Hotel Dieu de france Hospital"
            }, 
            "investigator": {
                "last_name": "Joseph Maarrawi, MD, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Lebanon"
        }, 
        "number_of_arms": "2", 
        "official_title": "Randomized Double-blind Trial Comparing the Post-operative Analgesic Efficacy of Local Wound Infiltration With Bupivacaine Alone to Bupivacaine With Clonidine in Posterior Spine Surgeries", 
        "overall_official": {
            "affiliation": "Laboratory of neurosciences, Faculty of medicine, St Joseph University of Beirut", 
            "last_name": "Joseph Maarrawi, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Lebanon: Ministry of Public Health", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Pain is assessed on numeric rating scale (NRS) 8times/day during the first 3 days, 3times/day during the next 6days and one mean value during the night. The mean intensity of daily pain is obtained from the different values mentioned during day and night corrected by the duration covered by every value. It may vary from 0 to 10.", 
            "measure": "Mean Area under curve", 
            "safety_issue": "No", 
            "time_frame": "From the day of surgery till the 8th postoperative day (9 days and 8 nights=200h"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01902108"
        }, 
        "responsible_party": {
            "investigator_affiliation": "St Joseph University, Beirut, Lebanon", 
            "investigator_full_name": "Dr Joseph Maarrawi", 
            "investigator_title": "Assistant Professor : Researcher - Pain Specialist - Neurosurgeon", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "The AUC during an interval (in days) is calculated by adding the different values of pain assessed during day and night multiplied by the duration (in hours) of sufferance from this amount of pain. The AUC during an interval is proportional to the mean intensity of pain suffered during the same interval. It is expressed in pain unit multiplied by hour", 
                "measure": "Area under Curve (AUC) of pain", 
                "safety_issue": "No", 
                "time_frame": "Calculated at Day 0-2, Day3-5, Day6-8 and all along the follow-up from Day0 till Day8"
            }, 
            {
                "description": "The unit of rescue opiates consumption equals the administration of 5mg of morphine subcutaneously. The minimum interval between 2 rescue opiates consumption is 6 hours. Thus, the rescue opiates consumption may vary from 0 to 4/day.", 
                "measure": "Daily rescue opiates consumption", 
                "safety_issue": "No", 
                "time_frame": "From the day of surgery till the 3rd postoperative day"
            }, 
            {
                "description": "It may vary from 0 that means a total dissatisfaction to 100% that means a complete satisfaction", 
                "measure": "Global subjective patient satisfaction of post-operative wound pain control", 
                "safety_issue": "No", 
                "time_frame": "Assessed at the end of follow-up on Day 8"
            }
        ], 
        "source": "St Joseph University, Beirut, Lebanon", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "St Joseph University, Beirut, Lebanon", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }
}